Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.160 | 18 | 49581427 | missense variant | T/A;C | snv | 4.0E-06; 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
1.000 | 0.080 | 18 | 49562460 | intron variant | C/G | snv | 0.25 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.200 | 18 | 49567494 | missense variant | C/A;T | snv | 4.0E-06; 0.27; 4.0E-06 | 0.23 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.827 | 0.160 | 18 | 49581427 | missense variant | T/A;C | snv | 4.0E-06; 4.0E-06 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2014 | 2019 | |||||||
|
0.763 | 0.200 | 18 | 49567494 | missense variant | C/A;T | snv | 4.0E-06; 0.27; 4.0E-06 | 0.23 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.827 | 0.160 | 18 | 49581427 | missense variant | T/A;C | snv | 4.0E-06; 4.0E-06 |
|
Cardiovascular Diseases | 0.060 | 0.833 | 6 | 2008 | 2019 | |||||||
|
0.763 | 0.200 | 18 | 49567494 | missense variant | C/A;T | snv | 4.0E-06; 0.27; 4.0E-06 | 0.23 |
|
Cardiovascular Diseases | 0.030 | 0.667 | 3 | 2009 | 2015 | ||||||
|
0.925 | 0.040 | 18 | 49569117 | intron variant | T/C | snv | 0.55 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.040 | 18 | 49561673 | 5 prime UTR variant | A/C;G | snv | 1.9E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.080 | 18 | 49586638 | intron variant | C/T | snv | 0.52 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.160 | 18 | 49581427 | missense variant | T/A;C | snv | 4.0E-06; 4.0E-06 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2014 | 2019 | |||||||
|
0.763 | 0.200 | 18 | 49567494 | missense variant | C/A;T | snv | 4.0E-06; 0.27; 4.0E-06 | 0.23 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2009 | 2009 | ||||||
|
0.763 | 0.200 | 18 | 49567494 | missense variant | C/A;T | snv | 4.0E-06; 0.27; 4.0E-06 | 0.23 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2010 | 2010 | ||||||
|
0.925 | 0.040 | 18 | 49569117 | intron variant | T/C | snv | 0.55 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.080 | 18 | 49586638 | intron variant | C/T | snv | 0.52 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
18 | 49583585 | missense variant | A/C;G | snv | 4.0E-06; 8.7E-03 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
0.763 | 0.200 | 18 | 49567494 | missense variant | C/A;T | snv | 4.0E-06; 0.27; 4.0E-06 | 0.23 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
|
0.763 | 0.200 | 18 | 49567494 | missense variant | C/A;T | snv | 4.0E-06; 0.27; 4.0E-06 | 0.23 |
|
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.827 | 0.160 | 18 | 49581427 | missense variant | T/A;C | snv | 4.0E-06; 4.0E-06 |
|
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
18 | 49583585 | missense variant | A/C;G | snv | 4.0E-06; 8.7E-03 |
|
0.700 | 1.000 | 3 | 2014 | 2018 | ||||||||||
|
18 | 49580782 | intron variant | C/A;G | snv |
|
0.700 | 1.000 | 2 | 2016 | 2018 | |||||||||||
|
18 | 49579658 | intron variant | C/T | snv | 5.6E-03 |
|
0.700 | 1.000 | 2 | 2017 | 2018 | ||||||||||
|
18 | 49593209 | 3 prime UTR variant | A/G | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
18 | 49572816 | intron variant | A/G | snv | 0.12 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
18 | 49559070 | upstream gene variant | C/T | snv | 0.11 |
|
0.700 | 1.000 | 1 | 2012 | 2012 |